A Review of β-Lactam-Associated Neutropenia and Implications for Cross-reactivity.

Future use of β-lactams with differing R1 side chains, particularly those from a separate class, should not be deemed contraindicated following β-lactam-induced neutropenia and may be considered when indicated, with close laboratory monitoring.